中国新药杂志

胰高血糖素样肽-1缓释微球技术进展

PDF下载

刘波 ¹ , 阮思达 ¹ , 蔡挺 ¹^,²

中国新药杂志 | 重大新药创制专项巡礼 2021,30(13): 1184-1191

收起

中国新药杂志 |重大新药创制专项巡礼 2021 , 30 (13) : 1184 -1191

胰高血糖素样肽-1缓释微球技术进展

全屏

刘波¹, 阮思达¹, 蔡挺¹^,²

作者信息

¹中国药科大学药学院药剂系，南京　210009

²中国药科大学天然药物活性组分与药效国家重点实验室，南京　210009

通讯作者:

蔡挺，男，博士生导师，教授，主要从事物理药剂学、药物晶体学、药物制剂工程、创新药物剂型设计和药物体内过程研究。联系电话：（025）83271123，E-mail：tcai@cpu.edu.cn。

作者简介:

刘波，女，硕士研究生，主要从事药物新型缓控释制剂研究。E-mail：better_lb@126.com。

Advances in the preparation technology of sustained-release microspheres of glucagon-like peptide-1 (GLP-1)

Bo LIU¹, Si-da RUAN¹, Ting CAI¹^,²

Affiliations

¹Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China

²State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China

出版时间: 2021-07-15

文章导航

摘要

收起

胰高血糖素样肽-1（GLP-1）是一种新型的具有血糖响应性质的降糖多肽，也为2型糖尿病的治疗提供了新的药物选择。然而GLP-1多肽的半衰期较短（约1~2 min），因此也限制了该多肽作为药物的应用。通过微球技术实现GLP-1的缓释治疗近年来受到了广泛关注。本文介绍了聚乳酸-聚羟基乙酸（PLGA）缓释微球用于包载GLP-1的制备方法，并且针对传统PLGA微球载药时面临的突释较大以及药物降解等问题，对新型的缓释微球技术（双层微球、自愈合多孔微球以及其他新型微球制剂）进行总结。这些新型微球技术能够有效提高蛋白药物的稳定性并能够得到长效的治疗效果，为蛋白类药物缓释微球的开发提供了新策略。

关键词

胰高血糖素样肽-1 / 聚乳酸-聚羟基乙酸 / 微球 / 缓释

Abstract

收起

Glucagon-like peptide-1 (GLP-1), considered as an effective peptide for the treatment of diabetes, can stimulate insulin secretion in response to rising glucose. Moreover, the novel peptide is becoming a new choice to treat type II diabetes. Nevertheless, the half-life of GLP-1 (approximately 1~2 min) is short, limiting its clinical application in diabetes. GLP-1-loaded PLGA microspheres have drawn more attentions in recent years. In this article, we introduces the preparation methods for encapsulation of GLP-1 in preparing PLGA microspheres. In order to solve the shortcomings of large burst release and drug degradation of traditional microspheres, some novel microsphere formulations (double-wall microspheres, self-healing microspheres and other new formulations of microspheres) are summarized. The new formulations effectively enhance protein stability and long-acting efficiency is achieved, providing new strategies for developing protein-loaded microspheres.

Key words

glucagon-like peptide-1 / PLGA / microspheres / sustained release

引用本文

刘波, 阮思达, 蔡挺. 胰高血糖素样肽-1缓释微球技术进展. 中国新药杂志, 2021 , 30 (13) : 1184 -1191 .

Bo LIU, Si-da RUAN, Ting CAI. Advances in the preparation technology of sustained-release microspheres of glucagon-like peptide-1 (GLP-1)[J]. Chinese Journal of New Drugs, 2021 , 30 (13) : 1184 -1191 .

基金

收起

国家“重大新药创制”科技重大专项资助项目(2017 XZ09301075)
国家自然科学基金资助项目(81872813)
中国药科大学“双一流”建设项目(CPU2018GY13)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

[1]

SHAW JE, SICREE RA, ZIMMET PZ. Global estimates of the prevalence of diabetes for 2010 and 2030[J]. Diabetes Res Clin Pract, 2010, 87(1): 4-14.

[2]

罗丹, 白曦晨, 陈丹, 等. 富硒青钱柳-黄精复方对糖尿病大鼠糖脂代谢和肝肾功能的影响[J]. 今日药学, 2021, 31(5): 353-356.

[3]

张敏杰, 方翼. rhGLP-1(7-36)对糖尿病肾病大鼠肾脏的保护机制研究[J]. 中国现代应用药学, 2021, 38(3): 281-285.

[4]

宋智慧, 王璐, 纪立伟, 等. GLP-1类似物在2型糖尿病中的临床应用进展[J]. 中国新药杂志, 2013, 22(5): 542-546, 555.

[5]

沙向阳, 王纳新, 邓欣. 糖尿病治疗新药-长效化胰高血糖素样肽-1(GLP-1)及其类似物的研究进展[J]. 海峡药学, 2011, 23(10): 1-6.

[6]

QI F, YANG LQ, WU J, et al. Microcosmic mechanism of dication for inhibiting acylation of acidic peptide[J]. Pharm Res, 2015, 32(7): 2310-2317.

[7]

QI F, WU J, FAN QZ, et al. Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability[J]. Colloids Surf B Biointerfaces, 2013, 112: 492-498.

[8]

WU J, WILLIAMS GR, BRANFORD-WHITE C, et al. Liraglutide-loaded poly(lactic-co-glycolic acid) microspheres: Preparation and in vivo evaluation[J]. Eur J Pharm Sci, 2016, 92: 28-38.

[9]

WANG PX, WANG Q, REN TY, et al. Effects of Pluronic F127-PEG multi-gel-core on the release profile and pharmacodynamics of Exenatide loaded in PLGA microspheres[J]. Colloids Surf B Biointerfaces, 2016, 147: 360-367.

[10]

李勋, 韦祎, 马光辉, 等. 缓释微球制剂的研究进展[J]. 北京化工大学学报(自然科学版), 2017, 44(6): 1-11.

[11]

HOLST JJ. The physiology of glucagon-like peptide 1[J]. Physiol Rev, 2007, 87(4): 1409-1439.

[12]

BELL GI, SANTERRE RF, MULLENBACH GT. Hamster preproglucagon contains the sequence of glucagon and two related peptides[J]. Nature, 1983, 302(5910): 716-718.

[13]

MOJSOV S, WEIR GC, HABENER JF. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent Stimulator of insulin release in the perfused rat pancreas[J]. J Clin Invest, 1987, 79(2): 616-619.

[14]

LUND A, KNOP FK, VILSBØLL T. Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities[J]. Eur J Intern Med, 2014, 25(5): 407-414.

[15]

贝凯, 等. 长效GLP-1受体激动剂的研发进展[J]. 微生物学免疫学进展, 2017, 45(1): 74-79.

[16]

齐峰. 粒径均-的PLGA颗粒制备及在长效缓释体系和Pickering乳液中的应用[D]. 中国科学院研究生院(过程工程研究所), 2015.

[17]

RAMAZANI F, CHEN W, VAN NOSTRUM CF, et al. Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges[J]. Int J Pharm, 2016, 499(1-2): 358-367.

[18]

QI F, WU J, HAO DX, et al. Comparative studies on the influences of primary emulsion preparation on properties of uniform-sized exenatide-loaded PLGA microspheres[J]. Pharm Res, 2014, 31(6): 1566-1574.

[19]

ICART LP, SOUZA FG Jr, LIMA LMTR. Sustained release and pharmacologic evaluation of human glucagon-like peptide-1 and liraglutide from polymeric microparticles[J]. J Microencapsul, 2019, 36(8): 747-758.

[20]

WEI Y, WANG YX, WANG W, et al. mPEG-PLA microspheres with narrow size distribution increase the controlled release effect of recombinant human growth hormone[J]. J Mater Chem, 2011, 21(34): 12691-12699.

[21]

YE ML, KIM S, PARK K. Issues in long-term protein delivery using biodegradable microparticles[J]. J Control Release, 2010, 146(2): 241-260.

[22]

WANG YT, SUN T, ZHANG Y, et al. Exenatide loaded PLGA microspheres for long-acting antidiabetic therapy: preparation, characterization, pharmacokinetics and pharmacodynamics[J]. RSC Adv, 2016, 6(44): 37452-37462.

[23]

QI F, WU J, YANG TY, et al. Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification[J]. Acta Biomater, 2014, 10(10): 4247-4256.

[24]

YUAN WE, LIU ZG. Controlled-release and preserved bioactivity of proteins from (self-assembled) core-shell double-walled microspheres[J]. Int J Nanomedicine, 2012, 7: 257-270.

[25]

LIU G, HONG XY, JIANG ME, et al. Sustained-release G-CSF microspheres using a novel solid-in-oil-in-oil-in-water emulsion method[J]. Int J Nanomedicine, 2012, 7: 4559-4569.

[26]

QIAN F, NI N, BURTON LS, et al. Sustained release subcutaneous delivery of BMS-686117, a GLP-1 receptor peptide agonist, via a zinc adduct[J]. Int J Pharm, 2009, 374(1-2): 46-52.

[27]

QUAGLIA F, DE ROSA G, GRANATA E, et al. Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying[J]. J Control Release, 2003, 86(2-3): 267-278.

[28]

ZHU C, HUANG Y, ZHANG XY, et al. Comparative studies on exenatide-loaded poly(D, L-lactic-co-glycolic acid) microparticles prepared by a novel ultra-fine particle processing system and spray drying[J]. Colloids Surf B Biointerfaces, 2015, 132: 103-110.

[29]

FREITAS S, MERKLE HP, GANDER B. Ultrasonic atomisation into reduced pressure atmosphere-envisaging aseptic spray-drying for microencapsulation[J]. J Control Release, 2004, 95(2): 185-195.

[30]

ARAÚJO F, SHRESTHA N, SHAHBAZI MA, et al. Microfluidic assembly of a multifunctional tailorable composite system designed for site specific combined oral delivery of peptide drugs[J]. ACS Nano, 2015, 9(8): 8291-8302.

[31]

LEE BK, YUN Y, PARK K. PLA micro- and nano-particles[J]. Adv Drug Deliv Rev, 2016, 107(16): 176-191.

[32]

KANKALA RK, LIN XF, SONG H, et al. Supercritical fluid-assisted decoration of nanoparticles on porous microcontainers for codelivery of therapeutics and inhalation therapy of diabetes[J]. Acs Biomater Sci Eng, 2018, 4(12): 4225-4235.

[33]

LEE TH, WANG J, WANG CH. Double-walled microspheres for the sustained release of a highly water soluble drug: characterization and irradiation studies[J]. J Control Release, 2002, 83(3): 437-452.

[34]

TAN EC, LIN RY, WANG CH. Fabrication of double-walled microspheres for the sustained release of doxorubicin[J]. J Colloid Interface Sci, 2005, 291(1): 135-143.

[35]

XU QX, CHIN SE, WANG CH, et al. Mechanism of drug release from double-walled PDLLA (PLGA) microspheres[J]. Biomaterials, 2013, 34(15): 3902-3911.

[36]

SHI M, YANG YY, CHAW CS, et al. Double walled POE/PLGA microspheres: encapsulation of water-soluble and water-insoluble proteins and their release properties[J]. J Control Release, 2003, 89(2): 167-177.

[37]

LEE WL, GUO WM, HO VHB, et al. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading[J]. Acta Biomater, 2015, 27: 53-65.

[38]

FREDENBERG S, WAHLGREN M, RESLOW M, et al. Pore formation and pore closure in poly(D, L-lactide-co-glycolide) films[J]. J Control Release, 2011, 150(2): 142-149.

[39]

MAZZARA JM, BALAGNA MA, THOULESS MD, et al. Healing kinetics of microneedle-formed pores in PLGA films[J]. J Control Release, 2013, 171(2): 172-177.

[40]

HUANG J, MAZZARA JM, SCHWENDEMAN SP, et al. Self-healing of pores in PLGAs[J]. J Control Release, 2015, 206: 20-29.

[41]

KANG JC, SCHWENDEMAN SP. Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins[J]. Mol Pharm, 2007, 4(1): 104-118.

[42]

XI X, NA X, SHUANG W, et al. Using self-healing microcapsules as antigen arsenal to elicit a prolonged anti-tumor response[J]. J Control Release, 2017, 259: e146.

[43]

DESAI KG, SCHWENDEMAN SP. Active self-healing encapsulation of vaccine antigens in PLGA microspheres[J]. J Control Release, 2013, 165(1): 62-74.

[44]

SHAH RB, SCHWENDEMAN SP. A biomimetic approach to active self-microencapsulation of proteins in PLGA[J]. J Control Release, 2014, 196: 60-70.

[45]

WANG PX, ZHUO XZ, CHU W, et al. Exenatide-loaded microsphere/thermosensitive hydrogel long-acting delivery system with high drug bioactivity[J]. Int J Pharm, 2017, 528(1-2): 62-75.

[46]

SHARAD K, ARCHANA G, ANDREAS D, et al. Hollow microparticles as a superior delivery system over solid microparticles for the encapsulation of peptides[J]. Pharm Res, 2018, 35(10): 185.

2021年第30卷第13期

PDF下载

引用本文

BibTeX

文章信息

首发时间：2026-10-30
出版时间：2021-07-15

补充材料

相关文章

文章信息

作者

出版历史

录用日期：2020-11-03

基金

国家“重大新药创制”科技重大专项资助项目(2017 XZ09301075)

国家自然科学基金资助项目(81872813)

中国药科大学“双一流”建设项目(CPU2018GY13)

作者信息

¹中国药科大学药学院药剂系，南京　210009

²中国药科大学天然药物活性组分与药效国家重点实验室，南京　210009

通讯作者:

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1322901723265769734

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT